Re-irradiation for Locally Recurrent Lung Cancer: Evidence, Risks and Benefits

R. Rulach*, G. G. Hanna, K. Franks, J. McAleese, S. Harrow

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

16 Citations (Scopus)


In spite of recent improvements in both the technical delivery of radiotherapy and systemic therapy in the treatment of non-small cell lung cancer, local recurrence rates after radiotherapy remain a significant challenge. In the setting of local relapse after radiotherapy, treatments such as surgical resection or radiofrequency ablation are often not appropriate owing to disease and patient factors. Re-irradiation may be a potential treatment option. This overview considers the published evidence and potential treatment strategies.

Original languageEnglish
Pages (from-to)101-109
Number of pages9
JournalClinical Oncology
Issue number2
Early online date06 Dec 2017
Publication statusPublished - Feb 2018


  • Lung cancer
  • radiotherapy
  • re-irradiation
  • retreatment

ASJC Scopus subject areas

  • Oncology
  • Radiology Nuclear Medicine and imaging


Dive into the research topics of 'Re-irradiation for Locally Recurrent Lung Cancer: Evidence, Risks and Benefits'. Together they form a unique fingerprint.

Cite this